Uni-Bio Science Group Ltd. (HK:0690) has recently secured a loan of RMB5,800,000 from internal resources for research, development, and operations. The biopharmaceutical company used two invention patents to secure the loan, which is set to last for 16 months starting from June 1, 2024. This news is significant for investors as it falls within a specific percentage ratio that requires announcement and reporting but does not need independent shareholder approval.
For those interested in learning more about HK:0690 stock and gaining additional insights, TipRanks’ Stock Analysis page offers valuable information.
